Regular vs as-needed inhaled salbutamol in asthma control
- 4 June 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 343 (8910), 1379-1382
- https://doi.org/10.1016/s0140-6736(94)92520-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.Thorax, 1993
- Beta agonists in asthma--state of the art: report on a Royal Society of Medicine seminar.Thorax, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Dose reduction of beta-agonists in asthmaThe Lancet, 1991
- Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthmaThe Lancet, 1990
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trialsJournal of Allergy and Clinical Immunology, 1986
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics *1A double-blind crossover studyJournal of Allergy and Clinical Immunology, 1979